Immediate Impact
55 standout
Citing Papers
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of N. Caria being referenced
Triplet therapy (continuous ribociclib, everolimus, exemestane) in HR+/HER2− advanced breast cancer postprogression on a CDK4/6 inhibitor (TRINITI-1): Efficacy, safety, and biomarker results.
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| N. Caria | 206 | 137 | 232 | 154 | 25 | 453 | |
| Tuija Wigren | 226 | 141 | 151 | 72 | 19 | 488 | |
| Takamichi Morikawa | 183 | 140 | 137 | 128 | 23 | 428 | |
| J. Graham Buckley | 176 | 183 | 285 | 223 | 22 | 475 | |
| Tian‐Tian Zhai | 163 | 79 | 129 | 147 | 34 | 462 | |
| Catherine Coyle | 154 | 160 | 185 | 242 | 21 | 460 | |
| Pierre Boisselier | 243 | 90 | 166 | 109 | 22 | 497 | |
| Felix Zwicker | 178 | 93 | 117 | 149 | 33 | 408 | |
| Giovanna Sartor | 227 | 86 | 111 | 73 | 22 | 436 | |
| Raffaele Solla | 118 | 158 | 79 | 94 | 24 | 466 | |
| Jean-Marie Deneufbourg | 181 | 85 | 102 | 139 | 35 | 486 |
All Works
Loading papers...